Life Science Compliance Update



Privacy Regulation: The Final Frontier of Life Science Compliance

Written by , Posted in Feature article

Matthew Gunzenhauser

Recently, as part of the course Legal Compliance Essentials for Drug, Device and Biotech Companies, Mitchell Hamline Law School, students were asked to write about what they saw as the important emerging issues for life sciences and what compliance professionals will need to do to adapt. Here is the first in a two-part series.


Topic tags:

Menu Title